# Functional Assessment in TAVI: FAITAVI

Study · id `cardio:ct-nct03360591` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT03360591](<https://clinicaltrials.gov/study/NCT03360591>), retrieved 26 October 2026. No person wrote or checked this page.

Also called: NCT03360591

Browse, organ or system: Heart  
Browse, condition area: Coronary and vascular disease; Valve and congenital heart disease  

## In plain language

A trial with no phase registered on ClinicalTrials.gov. The registry status is unknown. It plans to enroll 320 participants.

## Technical summary

Registry record NCT03360591. Randomized; no masking; primary purpose treatment. Start 2017-11-24 (actual); primary completion 2024-06-30 (actual). Results not posted.

## Key facts

- Design: Interventional study; randomized; no masking; primary purpose treatment
- Phase: Not applicable
- Enrolled: 320 participants (planned count; ClinicalTrials.gov record NCT03360591, source copy `cardio:ctgov-nct03360591-2025-03-21`, retrieved 2026-10-26)
- Started: 2017-11-24 (actual) (ClinicalTrials.gov record NCT03360591, source copy `cardio:ctgov-nct03360591-2025-03-21`, retrieved 2026-10-26)
- Primary completion: 2024-06-30 (actual) (ClinicalTrials.gov record NCT03360591, source copy `cardio:ctgov-nct03360591-2025-03-21`, retrieved 2026-10-26)
- Completion: 2025-06 (anticipated) (ClinicalTrials.gov record NCT03360591, source copy `cardio:ctgov-nct03360591-2025-03-21`, retrieved 2026-10-26)
- Countries: Italy (ClinicalTrials.gov record NCT03360591, source copy `cardio:ctgov-nct03360591-2025-03-21`, retrieved 2026-10-26)
- Care setting: Not reported
- Registry status: "UNKNOWN" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct03360591-2025-03-21`, retrieved 2026-10-26)

## The registry's words

- Brief title: Functional Assessment in TAVI: FAITAVI
- Acronym: FAITAVI
- Condition: Coronary Artery Disease
- Condition: Aortic Valve Stenosis
- Intervention (Device): Physiologically-guided strategy
- Lead sponsor: Universita di Verona
- Lead sponsor class: OTHER

## Connected pages

- Registry condition terms include this condition: Aortic stenosis (`cardio:aortic-stenosis`)
- Registry condition terms include this condition: Coronary artery disease (`cardio:coronary-artery-disease`)
- Registry condition terms include this condition: Heart valve disease (`cardio:heart-valve-disease`)

### Other papers using this trial's data

- Registry lists this paper as a derived reference; the paper's PubMed record names this trial's registry number and no other, PubMed types it as a trial report dated on or after the primary completion, neither its types nor its title mark it as a protocol, a design, an observational study or work outside the trial's own data, and PubMed shows no retraction or expression of concern: Physiology vs angiography-guided percutaneous coronary intervention in transcatheter aortic valve implantation: the FAITAVI trial (`cardio:pubmed-41417623`)

Courtesy of the U.S. National Library of Medicine.

## Provenance

Content hash: 5fc434b557b53f777eed8f79ab801fffd4444c7db63c4ac05b10676baaa564e2
Last substantive edit: 2026-11-08
Evidence last checked: Not recorded
